Ofyzone-S 375 Injection
Marketer
Medofy Pharmaceutical
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Ofyzone-S 375 Injection
Cefixime and Sulbactam injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be overseen by a physician. Complete the prescribed regimen, even with symptom improvement; premature cessation can compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects immediately. Seek urgent medical attention for allergic reactions (rash, pruritus, edema, dyspnea). Disclose all current medications, including those for pre-existing conditions, to your doctor before initiating treatment. Pregnant or lactating individuals require physician consultation. Alcohol should be avoided due to potential additive drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and ample hydration are crucial for optimal recovery. Monitoring may involve laboratory tests to assess the medication's impact.
Primary Ingredients of Ofyzone-S 375 Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Ofyzone-S 375 Injection
Infections caused by bacteria
Major Benefits of Ofyzone-S 375 Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Ofyzone-S 375 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ofyzone-S 375 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Ofyzone-S 375 Injection works:
The injectable formulation, Ofyzone-S 375, unites Ceftriaxone, a crucial antibiotic, with Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a process vital for bacterial viability. Sulbactam complements this by counteracting bacterial resistance mechanisms, thereby fortifying Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Ofyzone-S 375 Injection and alcohol does not produce adverse reactions.
PregnancySAFE IF PRESCRIBED
The injection Ofyzone-S 375 is typically deemed safe for use during gestation. Preclinical trials using animals revealed minimal or no negative consequences for the fetus; however, data from human trials are scarce.
Breast feedingCAUTION
The administration of Ofyzone-S 375 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Ofyzone-S 375 Injection may induce drowsiness, visual disturbances, or dizziness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Ofyzone-S 375 Injection use in individuals with impaired renal function is scarce. Seek medical advice from your physician.
LiverCAUTION
The administration of Ofyzone-S 375 Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Altering the Ofyzone-S 375 Injection dosage is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Ofyzone-S 375 Injection :
Omiting a scheduled Ofyzone-S 375 Injection warrants immediate physician consultation.
Facts to Know About Ofyzone-S 375 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently